Last Updated:

Saturday, December 3, 2022

4:41 PM

USA

BioCryst Pharmaceuticals

BioCryst designs and develops small molecule medicines for rare diseases like hereditary angioedema (HAE) and fibrodysplasia ossificans progressive (FOP).

BioCryst designs and develops small molecule medicines for rare diseases like hereditary angioedema (HAE) and fibrodysplasia ossificans progressive (FOP).

Newsroom